Back to Search
ROSARA TORRISI, LCSWR, MED, CST, PHD
LCSWR, MED, CST, PHD
Clinical Social Worker
NPI: 1588949796Individual
Specialties, Licenses & Credentials
Social Worker
Social Worker
Code: 104100000X
084150(NY)
Clinical Social WorkerPrimary
Social Worker — Clinical
Code: 1041C0700X
082289(NY)
Research & Publications (20)
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer.
PMID 19218304·Ann Oncol·2009
4-observational
The influence of attachment on perceived stress and cortisol response to acute stress in women sexually abused in childhood or adolescence.
PMID 19217212·Psychoneuroendocrinology·2009
2-rct
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
PMID 19182679·Anticancer Drugs·2009
5-case
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
PMID 18941889·Breast Cancer Res Treat·2009
3-trial
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
PMID 19562480·Breast Cancer Res Treat·2009
8-other
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.
PMID 18839307·Breast Cancer Res Treat·2009
3-trial
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
PMID 17986623·Ann Oncol·2008
8-other
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.
PMID 18506176·Br J Cancer·2008
8-other
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.
PMID 18941458·Br J Cancer·2008
8-other
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.
PMID 18794539·J Clin Oncol·2008
3-trial
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
PMID 18595702·Breast·2008
8-other
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
PMID 18456496·Breast·2008
8-other
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
PMID 18064460·Cancer Chemother Pharmacol·2008
3-trial
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17.
PMID 17855075·Eur J Cancer·2007
8-other
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer.
PMID 17716986·Ann Oncol·2007
8-other
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer.
PMID 17712311·Br J Cancer·2007
3-trial
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.
PMID 17578607·Support Care Cancer·2007
8-other
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre.
PMID 17260095·Breast Cancer Res Treat·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 35 ROOSEVELT AVE
SYOSSET, NY 11791 - Phone
- (516) 500-1085
Quick Facts
- NPI
- 1588949796
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile